← All trials
NCT05451771
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 26, 2022
- Primary completion
- Sep 30, 2026
- Completion date
- Sep 30, 2026
- First posted
- Jul 11, 2022
- Last posted
- Oct 28, 2022
- Enrollment
- 53
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Columbia UniversityLead sponsor
- GenentechCollaborator
- Columbia UniversityOverall official - principal investigator
- Columbia UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.